| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Revenue | $33.54B | +3.6% |
| Cost of Revenue | $11.63B | +3.7% |
| R&D Expense | $2.73B | -0.1% |
| SG&A Expense | $10.85B | +1.1% |
| Operating Income | $5.96B | +15.8% |
| Pre-tax Income | $5.63B | +16.4% |
| Income Tax | $936.0M | -17.4% |
| Net Income | $4.66B | +26.8% |
| EPS (Basic) | $3.63 |
| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.22B | +72.7% |
| Short-term Investments | $6.75B | +0.4% |
| Accounts Receivable | $6.51B | +6.3% |
| Inventory | $5.48B | +5.0% |
| Current Assets | $23.81B | +8.6% |
| Total Assets | $91.68B | +1.9% |
| Current Liabilities | $12.88B | +19.4% |
| Line Item | 2025-04-25 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.04B | +3.8% |
| Capital Expenditures | $1.86B | +17.1% |
| Investing Cash Flow | -$1.94B | +18.1% |
| Financing Cash Flow | -$4.36B | +2.0% |
| Free Cash Flow | $5.18B | -0.3% |
| +31.0% |
| EPS (Diluted) | $3.61 | +30.8% |
| Long-term Debt |
| $25.64B |
| +7.1% |
| Total Liabilities | $43.42B | +9.8% |
| Stockholders' Equity | $48.02B | -4.4% |